Analysis of pathogen distribution and association with lipid levels in patients with diabetic foot - Report - MDSpire

Analysis of pathogen distribution and association with lipid levels in patients with diabetic foot

  • By

  • Yan Chen

  • Weihong Chen

  • Yinxia Zhuo

  • May 22, 2026

  • 0 min

Share

Clinical Report: Investigation of Microbial Distribution and Its Correlation with Lipid Profiles in Diabetic Foot Patients

Overview

This study investigates the microbial distribution and antimicrobial resistance patterns in diabetic foot infection (DFI) patients, alongside their lipid profiles. Findings indicate no significant correlation between lipid levels and pathogen distribution or resistance patterns.

Background

Diabetic foot infections are a major complication of diabetes, leading to increased morbidity and risk of amputation. Understanding the microbial landscape and resistance patterns is crucial for effective treatment. Dyslipidemia is common in diabetic patients and may influence infection outcomes, yet its relationship with microbial profiles in DFI remains poorly understood.

Data Highlights

No significant differences were observed in lipid levels among different pathogen groups, or between drug-resistant and non-resistant infections (all p > 0.05).

Key Findings

  • Gram-positive bacteria were the most prevalent pathogens (54.12%) in DFI patients.
  • Staphylococcus aureus and Pseudomonas aeruginosa were the most common isolates.
  • Gram-positive bacteria showed high susceptibility to linezolid and vancomycin.
  • Gram-negative bacteria were most sensitive to amikacin and piperacillin-tazobactam.
  • Lipid profiles did not significantly correlate with pathogen distribution or antimicrobial resistance patterns.

Clinical Implications

Clinicians should be aware that lipid levels may not be a reliable indicator of microbial resistance in DFI. Accurate microbiological characterization remains essential for guiding appropriate antibiotic therapy in these patients.

Conclusion

The study highlights the need for further research to explore the complex interactions between lipid metabolism and infection characteristics in diabetic foot infections.

Related Resources & Content

  1. IWGDF/IDSA Guidelines on the Diagnosis and Treatment of Diabetes-related Foot Infections, Clinical Infectious Diseases, 2023 -- IWGDF/IDSA Guidelines
  2. Frontiers in Endocrinology, 2026 -- Analysis of infection characteristics and clinical predictive indicators of different bacterial diabetic foot in Yunnan area
  3. Infection, 2022 -- The Impact of Bacterial Presence and Sampling Techniques on Outcomes in Diabetic Foot Infections
  4. Frontiers in Immunology, 2026 -- Expression of lactylation-related genes and their correlation with diabetic foot ulcer occurrence and immune infiltration
  5. The Journal of Clinical Endocrinology & Metabolism — Characterization of Gut Microbiome Profiles and Metabolites Linked to Albuminuria in Individuals with Type 2 Diabetes
  6. IWGDF/IDSA Guidelines on the Diagnosis and Treatment of Diabetes-related Foot Infections (IWGDF/IDSA 2023) | Clinical Infectious Diseases | Oxford Academic
  7. Frontiers | A systematic review of diabetic foot infections: pathogenesis, diagnosis, and management strategies
  8. KDBH-LipidManagement-0225

Original Source(s)

Related Content